Literature DB >> 26791491

STIM and ORAI proteins: crucial roles in hallmarks of cancer.

A Fiorio Pla1, K Kondratska2, N Prevarskaya2.   

Abstract

Intracellular Ca(2+) signals play a central role in several cellular processes; therefore it is not surprising that altered Ca(2+) homeostasis regulatory mechanisms lead to a variety of severe pathologies, including cancer. Stromal interaction molecules (STIM) and ORAI proteins have been identified as critical components of Ca(2+) entry in both store-dependent (SOCE mechanism) and independent by intracellular store depletion and have been implicated in several cellular functions. In recent years, both STIMs and ORAIs have emerged as possible molecular targets for cancer therapeutics. In this review we focus on the role of STIM and ORAI proteins in cancer progression. In particular we analyze their role in the different hallmarks of cancer, which represent the organizing principle that describes the complex multistep process of neoplastic diseases.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  Ca2+; ORAI; STIM; cancer

Mesh:

Substances:

Year:  2016        PMID: 26791491     DOI: 10.1152/ajpcell.00364.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  25 in total

Review 1.  Molecular mechanisms of tumour invasion: regulation by calcium signals.

Authors:  Oksana Iamshanova; Alessandra Fiorio Pla; Natalia Prevarskaya
Journal:  J Physiol       Date:  2017-04-21       Impact factor: 5.182

2.  Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines.

Authors:  Cristina Pierro; Xuexin Zhang; Cynthia Kankeu; Mohamed Trebak; Martin D Bootman; H Llewelyn Roderick
Journal:  Cell Calcium       Date:  2018-03-14       Impact factor: 6.817

Review 3.  Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview.

Authors:  Dietrich Büsselberg; Ana-Maria Florea
Journal:  Cancers (Basel)       Date:  2017-05-09       Impact factor: 6.639

4.  Store operated calcium entry is altered by the inhibition of receptors tyrosine kinase.

Authors:  Noémie Emeriau; Marie de Clippele; Philippe Gailly; Nicolas Tajeddine
Journal:  Oncotarget       Date:  2018-03-23

5.  Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.

Authors:  Michael P Marciel; Vedbar S Khadka; Youping Deng; Pascal Kilicaslan; Andrew Pham; Pietro Bertino; Katie Lee; Suzie Chen; Natalija Glibetic; FuKun W Hoffmann; Michelle L Matter; Peter R Hoffmann
Journal:  Oncotarget       Date:  2018-02-03

6.  Quiescence status of glioblastoma stem-like cells involves remodelling of Ca2+ signalling and mitochondrial shape.

Authors:  Francisco J Aulestia; Isabelle Néant; Jihu Dong; Jacques Haiech; Marie-Claude Kilhoffer; Marc Moreau; Catherine Leclerc
Journal:  Sci Rep       Date:  2018-06-27       Impact factor: 4.379

Review 7.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

8.  Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia.

Authors:  Hélène Cabanas; Thomas Harnois; Christophe Magaud; Laëtitia Cousin; Bruno Constantin; Nicolas Bourmeyster; Nadine Déliot
Journal:  Oncotarget       Date:  2018-05-29

9.  Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal.

Authors:  Abdallah Mound; Alexia Vautrin-Glabik; Arthur Foulon; Béatrice Botia; Frédéric Hague; Jan B Parys; Halima Ouadid-Ahidouch; Lise Rodat-Despoix
Journal:  Oncotarget       Date:  2017-08-18

Review 10.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.